Diagnosis and management of type I and type V hyperlipoproteinemia

Journal of Atherosclerosis and Thrombosis

Volumn 19, Issue 1, 2012, Pages 1-12

  Gotoda, Takanari ^a   Shirai, Koji ^b   Ohta, Takao ^c   Kobayashi, Junji ^d   Yokoyama, Shinji ^e,o   Oikawa, Shinichi ^f   Bujo, Hideaki ^g   Ishibashi, Shun ^h   Arai, Hidenori ⁱ   Yamashita, Shizuya ^j   Harada Shiba, Mariko ^k   Eto, Masaaki ^l   Hayashi, Toshio ^m   Sone, Hirohito ⁿ   Suzuki, Hiroaki ⁿ   Yamada, Nobuhiro ⁿ  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^f NIPPON MEDICAL SCHOOL   (Japan)

^g CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h JICHI MEDICAL UNIVERSITY   (Japan)

ⁱ KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^k NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^l OHU UNIVERSITY   (Japan)

^m NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁿ UNIVERSITY OF TSUKUBA   (Japan)

^o CHUBU UNIVERSITY   (Japan)

more..

Author keywords

Chylomicronemia; Gene mutation; Hyperlipidemia; Lipase; Triglyceridemia

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; APOLIPOPROTEIN E; CELL PROTEIN; CHYLOMICRON; GPIHBP1 PROTEIN; HEPARIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; UNCLASSIFIED DRUG;

ACUTE PANCREATITIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHROMOSOME 8; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; HEPATOSPLENOMEGALY; HOMOZYGOTE; HUMAN; HYPERLIPOPROTEINEMIA TYPE 1; HYPERLIPOPROTEINEMIA TYPE 5; JAPANESE; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; PRACTICE GUIDELINE;

DISEASE MANAGEMENT; HUMANS; HYPERLIPOPROTEINEMIA TYPE I; HYPERLIPOPROTEINEMIA TYPE V; LIPOPROTEIN LIPASE; PRACTICE GUIDELINES AS TOPIC;

EID: 84863413709     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.10702     Document Type: Article

References (45)

1. Fredrickson DS, Lees RS: Familial hyperlipoproteinemia. in The Metabolic Basis of Inherited Disease (ed. by Stanbury JB, Wyngaarden JB, and Fredrickson DS), 2nd ed., New York, McGraw-Hill, 1966, pp429
2. Brunzell JD, Deeb SS: Familial lipoprotein lipase deficiency, apoC-II deficiency and hepatic lipase deficiency. in The Metabolic and Molecular Bases of Inherited Disease (ed. by Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, and Vogelstein B), 8th ed., New York, McGraw-Hill, 2000, pp2789-2816
3. Brunzell JD, Miller NE, Alaupovic P, St Hilaire RJ, Wang CS, Sarson DL, Bloom SR, Lewis B: Familial chylomicronemia due to a circulating inhibitor of lipoprotein lipase activity. J Lipid Res, 1983; 24: 12-19
4. Kihara S, Matsuzawa Y, Kubo M, Nozaki S, Funahashi T, Yamashita S, Sho N, Tarui S: Autoimmune hyperchylomicronemia. N Engl J Med, 1989: 320; 1255-1259
5. Beigneux AP, Davies BSJ, Gin P, Weinstein MM, Farber E, Qiao X, Peale F, Bunting S, Walzem RL, Wong JS, Blaner WS, Ding Z-M, Melford K, Wongsiriroj N, Shu X, de Sauvage F, Ryan RO, Fong LG, Bensadoun A, Young SG: Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons. Cell Metab, 2007; 5: 279-291
6. Peterfy M, Ben-Zeev O, Mao HZ, Weissglas-Volkov D, Aouizerat BE, Pullinger CR, Frost PH, Kane JP, Malloy MJ, Reue K, Pajukanta P, Doolittle MH: Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nature Genet, 2007; 39: 1483-1487
7. Murase T, Ohkubo M: Investigation on the molecular basis of hyperchylomicronemia. Therapeutic Res, 2000; 21: 2347-2352 (in Japanese)
8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285: 2486-2497
9. The report by the Study Group on Primary Hyperlipidemia of the Ministry of Health and Welfare (Group leader: Tarui S), 1988 (in Japanese)
10. Bürger MB, Grütz O: Uber hepatosplenomegale Lipoidose mit xanthomatosen Veranderungen der Haut und Schleimhaut. Arch Dermatol Syph, 1932; 166: 542-544
11. Havel RJ, Gordon RS Jr: Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest, 1960; 39: 1777-1790
12. Auwerx JH, Babirak SP, Fujimoto WY, Iverius PH, Brunzell JD: Defective enzyme protein in lipoprotein lipase deficiency. Eur J Clin Invest, 1989; 19: 433-437
13. Wion KL, Kirchgessner TG, Lusis AJ, Schotz MC, Lawn RM: Human lipoprotein lipase complementary DNA sequence. Science 1987; 235: 1638-1641
14. Senda M, Oka K, Brown WV, Qasba PK, Furuichi Y: Molecular cloning and sequence of a cDNA coding for bovine lipoprotein lipase. Proc Natl Acad Sci USA, 1987; 84: 4369-4373
15. Deeb SS, Peng RL: Structure of the human lipoprotein lipase gene. Biochemistry, 1989; 28: 4131-4135
16. Wilson DE, Emi M, Iverius PH, Hata A, Wu LL, Hillas E, Williams RR, Lalouel JM: Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J Clin Invest 1990; 86: 735-750
17. Ma Y, Ooi TC, Liu MS, Zhang H, McPherson R, Edwards AL, Forsythe IJ, Frohlich J, Brunzell JD, Hayden MR: High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J Lipid Res, 1994; 35: 1066-1075
18. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagné SE, Hayden M: Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med, 1996; 335: 848-854
19. Ebara T, Okubo M, Horinishi A, Adachi M, Murase T, Hirano T: No evidence of accelerated atherosclerosis in a 66-yr-old chylomicronemia patient homozygous for the nonsense mutation (Tyr61->stop) in the lipoprotein lipase gene. Atherosclerosis, 2001; 159: 375-379
20. Kawashiri MA, Higashikata T, Mizuno M, Takata M, Katsuda S, Miwa K, Nozue T, Nohara A, Inazu A, Kobayashi J, Koizumi J, Mabuchi H: Long-term course of lipoprotein lipase (LPL) deficiency due to homozygous LPL(Arita) in a patient with recurrent pancreatitis, retained glucose tolerance, and atherosclerosis. J Clin Endocrinol Metab, 2005; 90: 6541-6544
21. Ikeda Y, Takagi A, Ohkaru Y, Nogi K, Iwanaga T, Kurooka S, Yamamoto A: A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in human postheparin plasma using monoclonal antibodies to the corresponding enzymes. J Lipid Res, 1990; 31: 1911-1924
22. Kobayashi J, Hashimoto H, Fukamachi I, Tashiro J, Shirai K, Saito Y, Yoshida S: Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clin Chim Acta, 1993; 216: 113-123
23. Kawamura M, Gotoda T, Mori N, Shimano H, Kozaki K, Harada K, Shimada M, Inaba T, Watanabe Y, Yazaki Y, Yamada N: Establishment of enzyme-linked immunosorbent assays for lipoprotein lipase with newly developed antibodies. J Lipid Res, 1994; 35: 1688-1697
24. Gilbert B, Rouis M, Griglio S, de Lumley L, Laplaud P: Lipoprotein lipase (LPL) deficiency: a new patient homozygote for the preponderant mutation Gly188Glu in the human LPL gene and review of reported mutations: 75 % are clustered in exons 5 and 6. Ann Genet, 2001; 44: 25-32
25. http://www.ncbi.nlm.nih.gov/books/NBK1308/
26. Maruyama T, Yamashita S, Matsuzawa Y, Bujo H, Takahashi K, Saito Y, Ishibashi S, Ohashi K, Shionoiri F, Gotoda T, Yamada N, Kita T; Research Committee on Primary Hyperlipidemia of the Ministry of Health and Welfare of Japan: Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996-. J Atheroscler Thromb, 2004; 11: 131-145
27. Gotoda T, Yamada N, Kawamura M, Kozaki K, Mori N, Ishibashi S, Shimano H, Takaku F, Yazaki Y, Furuichi Y, Murase T: Heterogeneous mutations in the human lipoprotein lipase gene in patients with familial lipoprotein lipase deficiency. J Clin Invest, 1991; 88: 1856-1864
28. Takagi A, Ikeda Y, Tsutsumi Z, Shoji T, Yamamoto A: Molecular studies on primary lipoprotein lipase (LPL) deficiency. One base deletion (G916) in exon 5 of LPL gene causes no detectable LPL protein due to the absence of LPL mRNA transcript. J Clin Invest, 1992; 89: 581-591
29. Kozaki K, Gotoda T, Kawamura M, Shimano H, Yazaki Y, Ouchi Y, Orimo H, Yamada N: Mutational analysis of human lipoprotein lipase by carboxy-terminal truncation. J Lipid Res, 1993; 34: 1765-1772
30. Takagi A, Ikeda Y: Measurements of lipoprotein lipase (LPL) activity and immunoreactive mass, and diagnosis of LPL gene. Nippon Rinsho, 2007; 65 (Suppl 7): 182-1890 (in Japanese)
31. Zsigmond E, Kobayashi K, Tzung KW, Li L, Fuke Y, Chan L: Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice. Hum Gene Ther, 1997; 8: 1921-1933
32. Breckenridge WC, Little JA, Steiner G, Chow A, Poapst M: Hypertriglyceridemia associated with deficiency of apolipoprotein C-II. N Engl J Med, 1978; 298: 1265-1273
33. Yamamura T, Sudo H, Ishikawa K, Yamamoto A: Familial type I hyperlipoproteinemia caused by apolipoprotein C-II deficiency. Atherosclerosis, 1979; 34: 53-65
34. Jackson CL, Bruns GA, Breslow JL: Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII. Proc Natl Acad Sci USA, 1984; 81: 2945-2949
35. Fojo SS, Law SW, Brewer HB Jr: The human preproapolipoprotein C-II gene. Complete nucleic acid sequence and genomic organization. FEBS Lett, 1987; 213: 221-226
36. Fredrickson DS, Levy RI: Familial hyperlipoproteinemia, in The Metabolic Basis of Inherited Disease (ed. by Stanbury JB, Wyngaarden JB, and Fredrickson DS), 3rd ed. New York, McGraw-Hill, 1972, pp 545-614
37. Xiong WJ, Li WH, Posner I, Yamamura T, Yamamoto A, Gotto AM Jr, Chan L: No severe bottleneck during human evolution: evidence from two apolipoprotein C-II deficiency alleles. Am J Hum Genet, 1991; 48: 383-389
38. Inadera H, Hibino A, Kobayashi J, Kanzaki T, Shirai K, Yukawa S, Saito Y, Yoshida S: A missense mutation (Trp 26->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama). Biochem Biophys Res Commun, 1993; 193: 1174-1183
39. Okubo M, Hasegawa Y, Aoyama Y, Murase T: A G+1 to C mutation in a donor splice site of intron 2 in the apolipoprotein (apo) C-II gene in a patient with apo C-II deficiency. A possible interaction between apo C-II deficiency and apo E4 in a severely hypertriglyceridemic patient. Atherosclerosis, 1997; 130: 153-160
40. Murase T: Guidelines for the Diagnosis and Treatment of Hyperlipidemia. (Bunkodo) 2005, pp100 (in Japanese)
41. Marçais C, Verges B, Charrière S, Pruneta V, Merlin M, Billon S, Perrot L, Drai J, Sassolas A, Pennacchio LA, Fruchart-Najib J, Fruchart JC, Durlach V, Moulin P: Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest, 2005; 115: 2862-2869
42. Zhang H, Reymer PW, Liu MS, Forsythe IJ, Groenemeyer BE, Frohlich J, Brunzell JD, Kastelein JJ, Hayden MR, Ma Y: Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291->Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol, 1995; 15: 1695-1703
43. Yang WS, Nevin DN, Iwasaki L, Peng R, Brown BG, Brunzell JD, Deeb SS: Regulatory mutations in the human lipoprotein lipase gene in patients with familial combined hyperlipidemia and coronary artery disease. J Lipid Res, 1996; 37: 2627-2637
44. Zhang Q, Cavallero E, Hoffmann MM, Cavanna J, Kay A, Charles A, Braschi S, Marz W, Perlemuter L, Jacotot B, Galton DJ: Mutations at the lipoprotein lipase gene locus in subjects with diabetes mellitus, obesity and lipaemia. Clin Sci (Lond), 1997; 93: 335-341
45. Arai T, Tsukada T, Okubo M, Murase T, Matsumoto K: Ser477Stop mutation of the lipoprotein lipase gene occurs at a higher frequency in Japanese subjects with normal triglyceride levels than in hypertriglyceridemic patients. Atherosclerosis, 1999; 147: 417-420